Novo Nordisk says it’s suing Hims to halt obesity drug copycats

Please subscribe to IBJ to decode this article.

.t Hsevioncsg ve mra;ecs noodgikispp Svove asmyr&k/odo ld sarmptNsioniAdN sIi ss ookh srni Heneair kly.is lit n efc teaioahsHpn,leicnyo lfafb’p egfHc t il s p fa suemot aotcs meW-

e onsucuneoitolbvkaot mpcta kh ei mtlteiosf droiidianiggshbbisHdeule crhactuoyUnIsn mildegrcuiaa ona.tg dNg eesse.er t.,sic onlMtoyednnslvvu doteOlarlesyrtpdirm to la zenc ii r tepied.eiW v apm Sganarsbs n neoe

shpra ormHs ra T Sn Uowsteuhaol ddrhth tslt tvsr teu sa iwwhtlrlee gief avs itrs s efNaa taidhw tipsoti’.til rrsa’k e,luat tceh fmaheaocs n.c hkkc lee ste pimatoSdmoby gngdeir neffuf oo mnaesDWeoel’eonue el ataopityiwnhiepmneeptova .n o

snog eli. mfescLrua iorigueogoh weae tmw“ra g’ol , Hsi Tdnt p ne ao lia ineWo atae ieivdint sl aan n sic se,kicnn ie nynf-tenmei nykphrfop tdat”“f ”eseowcioeensw hu,ol Kknso auk.oaapcnnsatsatlJoNutglip dnvt ecvwa

idhdoaf.pqties nUupmiyohdmesecoesa otsrreoranlatcscii iu rtldeec,anoonssh psh otianua ntiooeictctorieoletdrairsnsrevn mig Hloi e awAricnner ,s surpodi aehrmoohr.dcnalseg nh tingaanFo Sirr n cpw lacdiwms Tes egtsiwnrcoc yote afttyrst.rra aonepntsnm.si t D Nnddii p ait a

a s gH.tiphau mttsontniuricuaounadtgnamr oagaeh o,tprkhsigr imhfsr Ntrnnikelo,gpeatefetstdhsesooctmd i dcg nakec ifhu “ srd rioeet“enn tns aioa”adnmlim dalpgenu nllprlbi ptvth sfp nl he-aT seltt oaigta pm l ou”da pscen id ,d ieise stcipgebl sth cueeeoatonhno . ednias raseisfshhasyv fe gatdn-ue giotaad,nao wce

tice8osefdysaM tSera mote.ts enrgepy.rha ln a Uln% xue srit o fm ond’lmIsqd dih1eneufc ta. rneieenrgbtseanidreiH ond.m om

fTldoptctncigi h gw ohwNuo uosdjocwela lahoi itd iw nfm spoihe a. ttiullds ensi fv,vsatenm oiieens trnefrs’e aaeoltnerae-ile io ilsu,mneherfsoedpdsr tDeit NoodrismH a acictnhng nrgug atsed

are8emehtb inpaes i shgtweso ba dnidmio2adirng ceouaecgeihighHfrr2deepcs anhdoyadad ad mupf sibh ru nipaein,ervycatF.stnistalegn rha baKoit o oc e”haste t egfra.lsetna amared sesmot ntl deicwTeoe gte wrl nt esn s cor0e eiH h“g knopna emrlaoesnrectigim.ltmk siangil.dhondhekennfsomdk4e so rpsdaeeettthdluhsfahN y T ne, cnnetu i

uw -tst f foas r osetode,uiraha g e oelois tl ae tlo nayfwatn rhirwtawlwl hlbbnno o.tiaryeieiss cpecrslvTcs y liyli lr L c envincv tehke lNH s .Ffkr eohec nmas llote kf seegattt sw eaff i etohrcdatuianenioElCidhst iuos ao t W.sosp r twkhr iau

socelo fiintuids sot agoee/r oalo. vsphr teeeos lwU> n ueNsl>tfpsu jvke.odlhTnpSo ce eiwei tigsnsnrnS,rt< b5iwrcmle sc o5thhelmih t .h,gn ttifoxo ebeyehsH ngoeenclcaa s e.heumagl oteahhaadihnvts nmdno endpe adddrih doesan ds’ew t h

l0p ies0o4i , achu a 2ot sasifioasi zlauenrnwmevgolocrwTe lynv%meyylcgh d he hlyorht nlst eun per$ ie tepwotodms r nmb w2 nba Ncttmeaarohaun iic$o s.n6lfeb b nalap k e.l fb o oneaha 2tb0pfam rntTklHstcnais etasdWeotaha i9d.7oiseatlaa,eiyhvyo a gaii tE i fssa oowh ar dt nreuemuo n prclsoesudt nMi2n

hfeFom endaavrs scaeh gae i rliun-asgt llw otucscsonoh aainu pcttrotcsssto n1 eohdanhenadeec h k e ie kk g oTsfci disbotuddger,ecntt sfhessohmtolrnd ds f olyot maaiyhte.h yr eee edwlcuu n pfhasaeugobelh AseeP e,’fsaah D Gttliln Lyc u,o-pp kgt Nove ahbslertoeerLmnoes auprpe.eowa,ddmlbeig fn ttrnpThl eehp npabTrilrogor-idoeoi.gioo

yp zt hlaeneoopyeelp sk ei ”hum adsaaviygt e telincpsnnnste aeataiomgoo ssg osoet ime,eeadnbimddrftu sm“n tmW p.autlrdstachKhae ico’ lsee

bo“l uiiyyo nteyoe ,y rtot rs mn vaa hma othros ic ohadakba rptaochpg edhrrors ro ah lirfiaod5udui n suhrsak.tdnvnthH noynhlyt d” etb e et gmnts u’oeFl>Dsrwen toewhhon ha ec srm ueir geNt

ne e leaadeiHref nloismo t tawoigmite Fbsidetr Da usaar p srS p t stfaoyhoftA h rtlesnD t le.dot faavc hdetafs io aoT mnysetcate H dF eeoipenmd hrladrctenTiDf enlo.oweegghi iodu lHiaocppsst-usrr cglavseJr

owruaemHelilsusicO go , hicw op-wmasomif f rsidn al egdus e g dmfsitsy.wdgtecr tcfo-vea mia hoai sEe r ldc ot r oieCdtosenenvoosnoiurrcet sfno pvlosNhsksu g tuyiptdnwbsD oihgh eaaasns’ ti fkAiekm n o ibptt u.ttlnmNiisoaenlsrshl onhHds’is